The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
In order to address environmental sustainability in the pharmaceutical industry, a holistic approach is needed to address environmental footprint from both operations and products. In this session, seven sustainability experts and senior leaders from Roche/Genentech, GSK, and Takeda will share how they have advanced tools to identify opportunities to minimize their environmental footprint, developed operations and product sustainability roadmaps, and have implemented innovative technologies to decarbonize their operations and reduce their environmental footprints.
1005 – 1015: Roche's 10-year Ambition to Halve Total Environmental Impact of its Operations by Behzad Torabifar 1015 – 1025: Sustainability Modeling & Analysis for Large Scale Biopharma Drug Substance (DS) Operations by Ken Hamilton 1025 – 1035: Steam-generating Heat Pumps; Water Reduction by Utilizing Recovered Reverse Osmosis (RO) Concentrate by Harald Erös 1035 – 1045: REVERSE OSMOSIS (RO) REJECT RECOVERY FOR COOLING TOWERS by Gregory Groberman 1045 – 1105: GSK Approach to Ecodesign for Development of More Sustainable Products, Processes, Packaging and Devices by Daniel D'Aquila 1105 – 1130: Question and Answer/Panel Discussion moderated by Behzad Torabifar